Marrow Transplantation for Nonmalignant Disorders

Publisher Website
Google Scholar
Abstract
IN 1978 Parkman et al.1 reported the complete correction of the Wiskott–Aldrich syndrome in two patients by allogeneic marrow transplantation after preparation with antihuman thymocyte serum and total-body irradiation. The article and the accompanying editorial2 indicated the potential of marrow transplantation for the correction of a wide variety of nonmalignant diseases. Five years and many reports later, it is apparent that much progress has been made but that many problems remain.The modern era of human bone-marrow transplantation began at the end of the 1960s, when techniques of human histocompatibility typing made it possible to select HLA-identical siblings as donors. . . .